{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"submitter":["Li D"],"funding":["Natural Science Foundation of Guangdong Province","Fujian Provincial Department of Finance"],"pagination":["1042-1056"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8524015"],"repository":["biostudies-literature"],"omics_type":["Unknown"],"volume":["53(4)"],"pubmed_abstract":["<h4>Purpose</h4>Drug resistance is one of the main causes of chemotherapy failure in patients with small cell lung cancer (SCLC), and extensive biological studies into chemotherapy drug resistance are required.<h4>Materials and methods</h4>In this study, we performed lncRNA microarray, in vitro functional assays, in vivo models and cDNA microarray to evaluate the impact of lncRNA in SCLC chemoresistance.<h4>Results</h4>The results showed that KCNQ1OT1 expression was upregulated in SCLC tissues and was a poor prognostic factor for patients with SCLC. Knockdown of KCNQ1OT1 inhibited cell proliferation, migration, chemoresistance and promoted apoptosis of SCLC cells. Mechanistic investigation showed that KCNQ1OT1 can activate transforming growth factor-β1 mediated epithelial-to-mesenchymal tr"],"journal":["Cancer research and treatment"],"pubmed_title":["Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition."],"pmcid":["PMC8524015"],"funding_grant_id":["Fujian Finance Document (2019) 926","2016A030313137"],"pubmed_authors":["Wen Y","Liang S","Liu H","Tong Q","Li D","Zhu Y","Lian Y","Li M","Zheng J","Liu Z","Guo L","Wang Q","Chen Z","Huang W"],"additional_accession":[]},"is_claimable":false,"name":"Inhibition of lncRNA KCNQ1OT1 Improves Apoptosis and Chemotherapy Drug Response in Small Cell Lung Cancer by TGF-β1 Mediated Epithelial-to-Mesenchymal Transition.","description":"<h4>Purpose</h4>Drug resistance is one of the main causes of chemotherapy failure in patients with small cell lung cancer (SCLC), and extensive biological studies into chemotherapy drug resistance are required.<h4>Materials and methods</h4>In this study, we performed lncRNA microarray, in vitro functional assays, in vivo models and cDNA microarray to evaluate the impact of lncRNA in SCLC chemoresistance.<h4>Results</h4>The results showed that KCNQ1OT1 expression was upregulated in SCLC tissues and was a poor prognostic factor for patients with SCLC. Knockdown of KCNQ1OT1 inhibited cell proliferation, migration, chemoresistance and promoted apoptosis of SCLC cells. Mechanistic investigation showed that KCNQ1OT1 can activate transforming growth factor-β1 mediated epithelial-to-mesenchymal tr","dates":{"release":"2021-01-01T00:00:00Z","publication":"2021 Oct","modification":"2025-04-19T17:42:04.968Z","creation":"2024-11-20T07:19:01.908Z"},"accession":"S-EPMC8524015","cross_references":{"pubmed":["33705625"],"doi":["10.4143/crt.2020.1208"]}}